MST has an absolute focus on value creation for our clients. MST's innovative platform enables the best talent in financial services to collaborate with clients in an exclusive partnership.
MST offers institutional research through its Marquee platform and issuer sponsored equity research through its Access platform.
Sep 09, 2021
MST Financial is delighted to announce the MST Access Strategic Market Outlook webinar will be taking place on Tuesday, 14 September at 4.00pm (AEST).
Aug 30, 2021
MST Financial is proud to have supported Carina Biotech with its $5.4 million pre-IPO equity raising, acting as Lead Manager to the offer.
Aug 30, 2021
MST Financial is delighted to be appointed Lead Manager and Bookrunner for Kyckr's (KYK.ASX) $6 million equity raising.
Aug 08, 2021
MST Financial is proud to have supported Poseidon Nickel Limited with its $22 million equity raising, acting as Co-Manager to the offer.
Aug 05, 2021
MST Access Senior Research Analyst, Chris Kallos, CFA explores how Cynata Therapeutics (ASX:CYP) is unlocking the potential of stem cells in developing therapeutic products to treat serious disorders.
Jul 29, 2021
MST Financial is delighted to act as Joint Lead Manager in supporting PointsBet with its $400 million equity raising.